Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.42−0.85 (-16.13%)
Close on Nov 16, 2026Market cap $287.45MP/E –Yield –
Treace Medical Concepts gross margin
Gross margin is gross profit as a percentage of revenue.
Treace Medical Concepts's gross margin for the twelve months ending Jun 30, 2026 was 79.5%. For fiscal 2025 it was 79.8%, against 80.4% the year before. The highest annual figure on record is 82.1% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 79.8% | −0.6 |
| FY2024 | Dec 31, 2024 | 80.4% | −0.8 |
| FY2023 | Dec 31, 2023 | 81.2% | −0.8 |
| FY2022 | Dec 31, 2022 | 82.0% | −0.1 |
| FY2021 | Dec 31, 2021 | 82.1% | +3.9 |
| FY2020 | Dec 31, 2020 | 78.3% | −2.4 |
| FY2019 | Dec 31, 2019 | 80.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 78.5% | −1.2 |
| Q1 FY2026 | Mar 31, 2026 | 79.3% | −0.4 |
| Q4 FY2025 | Dec 31, 2025 | 80.6% | −0.1 |
| Q3 FY2025 | Sep 30, 2025 | 79.1% | −1.1 |
| Q2 FY2025 | Jun 30, 2025 | 79.7% | −0.6 |
| Q1 FY2025 | Mar 31, 2025 | 79.7% | −0.5 |
| Q4 FY2024 | Dec 31, 2024 | 80.7% | −0.8 |
| Q3 FY2024 | Sep 30, 2024 | 80.1% | −0.2 |
| Q2 FY2024 | Jun 30, 2024 | 80.2% | −1.5 |
| Q1 FY2024 | Mar 31, 2024 | 80.2% | −0.8 |
| Q4 FY2023 | Dec 31, 2023 | 81.6% | −0.3 |
| Q3 FY2023 | Sep 30, 2023 | 80.4% | −1.2 |
| Q2 FY2023 | Jun 30, 2023 | 81.7% | −0.6 |
| Q1 FY2023 | Mar 31, 2023 | 80.9% | −1.4 |
| Q4 FY2022 | Dec 31, 2022 | 81.9% | −2.1 |
| Q3 FY2022 | Sep 30, 2022 | 81.6% | +1.2 |
| Q2 FY2022 | Jun 30, 2022 | 82.3% | +1.4 |
| Q1 FY2022 | Mar 31, 2022 | 82.3% | +0.1 |
| Q4 FY2021 | Dec 31, 2021 | 83.9% | +5.0 |
| Q3 FY2021 | Sep 30, 2021 | 80.4% | +0.8 |
| Q2 FY2021 | Jun 30, 2021 | 80.9% | +7.8 |
| Q1 FY2021 | Mar 31, 2021 | 82.2% | +3.4 |
| Q4 FY2020 | Dec 31, 2020 | 78.9% | – |
| Q3 FY2020 | Sep 30, 2020 | 79.6% | – |
| Q2 FY2020 | Jun 30, 2020 | 73.1% | – |
| Q1 FY2020 | Mar 31, 2020 | 78.8% | – |
See a number that looks wrong?